Omnicare Settles Fraud Charges For $49.5M

Law360, New York (November 14, 2006, 12:00 AM EST) -- Omnicare Inc., a leading provider of pharmaceutical care for the elderly, has agreed to pay $49.5 million to the federal government and 42 states to settle allegations that it overcharged Medicaid.

The settlement, which was announced Tuesday, comes out of a previously disclosed review in which the company was accused of substituting capsules for tablets of Ranitidine, a generic form of the heartburn drug Zantac; tablets instead of capsules of Fluoxetine, a generic form of the antidepressant Prozac; and two 7.5 mg tablets for a single...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.